Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01020305).
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tension Versus Tension- Free Foley Balloon for Cervical Ripening: Complete Statistical AnalysisIndependent statistical analysis of Tension Versus Tension- Free Foley Balloon for Cervical Ripening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05404776).
- Tepotinib Hepatic Impairment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tepotinib Hepatic Impairment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03546608).
- TESIndependent statistical analysis of The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TESSERACTIndependent statistical analysis of Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03574038).
- Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer:…
- Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I): Complete Statistical AnalysisIndependent statistical analysis of Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers: Complete Statistical AnalysisIndependent statistical analysis of Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W): Complete Statistical AnalysisIndependent statistical analysis of Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F): Complete Statistical AnalysisIndependent statistical analysis of Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth: Complete Statistical AnalysisIndependent statistical analysis of Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Financial Incentive Interventions in Dyadic-Smoker Couples: Complete Statistical AnalysisIndependent statistical analysis of Testing Financial Incentive Interventions in Dyadic-Smoker Couples: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04832360).
- Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH – Subprotocol Z1K): Complete Statistical AnalysisIndependent statistical analysis of Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1): Complete Statistical AnalysisIndependent statistical analysis of Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates: Complete Statistical AnalysisIndependent statistical analysis of Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565353).
- Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors: Complete Statistical AnalysisIndependent statistical analysis of Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03878095).
- Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH – Subprotocol Z1C): Complete Statistical AnalysisIndependent statistical analysis of Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC): Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC): primary endpoint results,…
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer,…
- Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval,…
- Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval,…
- Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone: Complete Statistical AnalysisIndependent statistical analysis of Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the…
- Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma: primary endpoint results, effect…
- Testing the Effectiveness of a Falls Prevention System: Complete Statistical AnalysisIndependent statistical analysis of Testing the Effectiveness of a Falls Prevention System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03678402).
- Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening: Complete Statistical AnalysisIndependent statistical analysis of Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495025).
- Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence…
- Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval,…
- Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tetra-NIRS Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Tetra-NIRS Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00871975).
- TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations: Complete Statistical AnalysisIndependent statistical analysis of TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Texting to Promote Breastfeeding (TOPS): Complete Statistical AnalysisIndependent statistical analysis of Texting to Promote Breastfeeding (TOPS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06375655).
- TH HSV REC-004Independent statistical analysis of A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years: primary endpoint results, effect estimate with…
- THACAIndependent statistical analysis of Thiamine as a Metabolic Resuscitator After Cardiac Arrest: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03450707).
- Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT): Complete Statistical AnalysisIndependent statistical analysis of Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- THAPCA-IHIndependent statistical analysis of Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- THAPCA-OHIndependent statistical analysis of Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- The ‘MADe IT’ Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- The Anesthetic Efficacy of 3% Mepivacaine Plus 2% Lidocaine With 1:100,000 Epinephrine for Lower Jaw Dental Injections: Complete Statistical AnalysisIndependent statistical analysis of The Anesthetic Efficacy of 3% Mepivacaine Plus 2% Lidocaine With 1:100,000 Epinephrine for Lower Jaw Dental Injections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- The CANTATA-M (CANagliflozin Treatment and Trial Analysis – Monotherapy) Trial: Complete Statistical AnalysisIndependent statistical analysis of The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01081834).
- The CASCADE HF Soft Launch and Calibration Phase I and II: Complete Statistical AnalysisIndependent statistical analysis of The CASCADE HF Soft Launch and Calibration Phase I and II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade: Complete Statistical AnalysisIndependent statistical analysis of The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…